MDR Transition Extension Period: Understanding the New Regulation 2023/607 for Device and IVD Manufacturers
On January 6, the EU Commission finally took steps towards addressing…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 352–360 of 635
On January 6, the EU Commission finally took steps towards addressing…
While established over ten years ago as a concept by the precursor to the International Medical Device Regulators Forum (IMDRF),…
Just as in clinical evaluation, literature searches are critical in the performance evaluation process under the IVDR. Scientific (peer-reviewed)…
Specific IVD performance evaluation documentation required under Article 56 of the IVDR includes: Performance Evaluation Plan (PEP)…
Even for those that have prepared a performance evaluation summary document for an IVD CE marked under the IVDD…
The EU MDR/IVDR establishes specific regulatory obligations for economic operators, including importers. The concept of “placing…
Given their scope, the labeling requirements established under the IVDR can be daunting for manufacturers, even for legacy device…
As we’ve previously reported for non-IVD devices, under the new Swiss Medical Devices Ordinance…
In this article, we share the advantages and disadvantages associated with consolidating the roles of authorized representative and importer.
Showing 352–360 of 635